ENOblock 1 (Figure 4), non-glycolytic inhibitor of ENO1, induce nuclear translocation of ENO1 and down-regulation of phosphoenolpyruvate carboxy kinase to inhibit the growth and migration of cancer cells 7,93,94. This evidence concerns the gene ENO1 and cancer.